{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T22:01:59Z","timestamp":1792620119016,"version":"4.5.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2024,3,2]],"date-time":"2024-03-02T00:00:00Z","timestamp":1709337600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2024,3,2]],"date-time":"2024-03-02T00:00:00Z","timestamp":1709337600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"name":"Openbanak"},{"DOI":"10.13039\/501100010198","name":"Ministerio de Asuntos Econ\u00f3micos y Transformaci\u00f3n Digital, Gobierno de Espa\u00f1a","doi-asserted-by":"publisher","award":["PID2021-122216OB-I00"],"award-info":[{"award-number":["PID2021-122216OB-I00"]}],"id":[{"id":"10.13039\/501100010198","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rheumatol Ther"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1007\/s40744-024-00650-9","type":"journal-article","created":{"date-parts":[[2024,3,2]],"date-time":"2024-03-02T09:02:00Z","timestamp":1709370120000},"page":"501-521","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Neutrophilic Activity Biomarkers (Plasma Neutrophil Extracellular Traps and Calprotectin) in Established Patients with Rheumatoid Arthritis Receiving Biological or JAK Inhibitors: A Clinical and Ultrasonographic Study"],"prefix":"10.1007","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5867-8434","authenticated-orcid":false,"given":"Beatriz","family":"Frade-Sosa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3068-5752","authenticated-orcid":false,"given":"Andr\u00e9s","family":"Ponce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Est\u00edbaliz","family":"Ruiz-Ortiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noem\u00ed","family":"De Moner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda J.","family":"G\u00f3mara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Bel\u00e9n","family":"Azuaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8426-7268","authenticated-orcid":false,"given":"Juan C.","family":"Sarmiento-Monroy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2892-6142","authenticated-orcid":false,"given":"Rosa","family":"Morl\u00e0","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2657-6601","authenticated-orcid":false,"given":"Virginia","family":"Ruiz-Esquide","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8314-3087","authenticated-orcid":false,"given":"Laura","family":"Mac\u00edas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nuria","family":"Sapena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lola","family":"Tobalina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julio","family":"Ramirez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2606-0573","authenticated-orcid":false,"given":"Juan D.","family":"Ca\u00f1ete","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1935-4488","authenticated-orcid":false,"given":"Jordi","family":"Yague","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6383-7308","authenticated-orcid":false,"given":"Josep M.","family":"Auge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8177-702X","authenticated-orcid":false,"given":"Jos\u00e9 A.","family":"Gomez-Puerta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8488-9975","authenticated-orcid":false,"given":"Odette","family":"Vi\u00f1as","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8677-2340","authenticated-orcid":false,"given":"Isabel","family":"Haro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8864-3806","authenticated-orcid":false,"given":"Raimon","family":"Sanmarti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,3,2]]},"reference":[{"key":"650_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2019.102400","volume":"110","author":"HU Scherer","year":"2020","unstructured":"Scherer HU, H\u00e4upl T, Burmester GR. The etiology of rheumatoid arthritis. J Autoimmun. 2020;110: 102400.","journal-title":"J Autoimmun"},{"key":"650_CR2","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1038\/s41584-019-0170-5","volume":"15","author":"R van Vollenhoven","year":"2019","unstructured":"van Vollenhoven R. Treat-to-target in rheumatoid arthritis\u2014are we there yet? Nat Rev Rheumatol. 2019;15:180\u20136.","journal-title":"Nat Rev Rheumatol"},{"key":"650_CR3","doi-asserted-by":"publisher","first-page":"S685","DOI":"10.1136\/annrheumdis-2019-216655","volume":"79","author":"JS Smolen","year":"2020","unstructured":"Smolen JS, Landew\u00e9 RBM, Bijlsma JWJ, Burmester GR, Dougados M, Kerschbaumer A, et al. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update. Ann Rheum Dis. 2020;79:S685\u201399.","journal-title":"Ann Rheum Dis"},{"key":"650_CR4","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1136\/annrheumdis-2015-207524","volume":"75","author":"JS Smolen","year":"2016","unstructured":"Smolen JS, Breedveld FC, Burmester GR, Bykerk V, Dougados M, Emery P, et al. Treating rheumatoid arthritis to target: 2014 update of the recommendations of an international task force. Ann Rheum Dis. 2016;75:3\u201315.","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"650_CR5","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.rdc.2005.09.005","volume":"32","author":"D Aletaha","year":"2006","unstructured":"Aletaha D, Smolen JS. The definition and measurement of disease modification in inflammatory rheumatic diseases. Rheumatic Disease Clinics of North America. Rheum Dis Clin North Am. 2006;32(1):9\u201344.","journal-title":"Rheum Dis Clin North Am"},{"key":"650_CR6","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1016\/j.autrev.2018.06.006","volume":"17","author":"I Cecchi","year":"2018","unstructured":"Cecchi I, Arias de la Rosa I, Menegatti E, Roccatello D, Collantes-Estevez E, Lopez-Pedrera C, et al. Neutrophils novel key players in rheumatoid arthritis. current and future therapeutic targets. Autoimmun Rev. 2018;17:1138\u201349.","journal-title":"Autoimmun Rev"},{"key":"650_CR7","doi-asserted-by":"publisher","first-page":"86","DOI":"10.7555\/JBR.33.20190075","volume":"34","author":"L Zhang","year":"2020","unstructured":"Zhang L, Yuan Y, Xu Q, Jiang Z, Chu CQ. Contribution of neutrophils in the pathogenesis of rheumatoid arthritis. J Biomed Res. 2020;34:86.","journal-title":"J Biomed Res"},{"key":"650_CR8","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.molmed.2018.12.008","volume":"25","author":"LJ O\u2019Neil","year":"2019","unstructured":"O\u2019Neil LJ, Kaplan MJ. Neutrophils in rheumatoid arthritis: breaking immune tolerance and fueling disease. Trends Mol Med. 2019;25:215\u201327.","journal-title":"Trends Mol Med"},{"key":"650_CR9","doi-asserted-by":"publisher","first-page":"1001025","DOI":"10.3389\/fimmu.2022.1001025","volume":"13","author":"J Inciarte-Mundo","year":"2022","unstructured":"Inciarte-Mundo J, Frade-Sosa B, Sanmart\u00ed R. From bench to bedside: calprotectin (S100A8\/S100A9) as a biomarker in rheumatoid arthritis. Front Immunol. 2022;13:1001025.","journal-title":"Front Immunol"},{"key":"650_CR10","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1002\/acr.22795","volume":"68","author":"J Inciarte-Mundo","year":"2016","unstructured":"Inciarte-Mundo J, Victoria Hern\u00e1ndez M, Ruiz-Esquide V, Raquel Cabrera-Villalba S, Ramirez J, Cuervo A, et al. Serum calprotectin versus acute-phase reactants in the discrimination of inflammatory disease activity in rheumatoid arthritis patients receiving tumor necrosis factor inhibitors. Arthritis Care Res (Hoboken). 2016;68:899\u2013906.","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"650_CR11","doi-asserted-by":"publisher","first-page":"1759720X2211141","DOI":"10.1177\/1759720X221114105","volume":"14","author":"B Frade-Sosa","year":"2022","unstructured":"Frade-Sosa B, Ponce A, Inciarte-Mundo J, Morl\u00e0 R, Ruiz-Esquide V, Mac\u00edas L, et al. Plasma calprotectin as a biomarker of ultrasound synovitis in rheumatoid arthritis patients receiving IL-6 antagonists or JAK inhibitors. Ther Adv Musculoskelet Dis. 2022;14:1759720X2211141.","journal-title":"Ther Adv Musculoskelet Dis"},{"key":"650_CR12","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1002\/acr.22795","volume":"68","author":"J Inciarte-Mundo","year":"2015","unstructured":"Inciarte-Mundo J, Hern\u00e1ndez MV, Ruiz-Esquide V, Cabrera-Villalba SR, Ramirez J, Cuervo A, et al. Serum Calprotectin more accurately discriminates the inflammatory disease activity of rheumatoid arthritis patients receiving tnf inhibitors than acute phase reactants. Arthritis Care Res (Hoboken). 2015;68:899\u2013906.","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"650_CR13","first-page":"2239","volume":"54","author":"J Inciarte-Mundo","year":"2015","unstructured":"Inciarte-Mundo J, Ruiz-Esquide V, Hern\u00e1ndez MV, Ca\u00f1ete JD, Cabrera-Villalba SR, Ramirez J, et al. Calprotectin more accurately discriminates the disease status of rheumatoid arthritis patients receiving tocilizumab than acute phase reactants. Rheumatology (Oxford). 2015;54:2239\u201343.","journal-title":"Rheumatology (Oxford)"},{"key":"650_CR14","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.1126\/science.1092385","volume":"303","author":"V Brinkmann","year":"2004","unstructured":"Brinkmann V, Reichard U, Goosmann C, Fauler B, Uhlemann Y, Weiss DS, et al. Neutrophil extracellular traps kill bacteria. Science. 2004;303:1532\u20135.","journal-title":"Science"},{"issue":"8","key":"650_CR15","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1038\/s41584-018-0039-z","volume":"14","author":"F Apel","year":"2018","unstructured":"Apel F, Zychlinsky A, Kenny EF. The role of neutrophil extracellular traps in rheumatic diseases. Nat Rev Rheumatol. 2018;14(8):467\u201375.","journal-title":"Nat Rev Rheumatol"},{"key":"650_CR16","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.578129","volume":"11","author":"W Song","year":"2020","unstructured":"Song W, Ye J, Pan N, Tan C, Herrmann M. Neutrophil extracellular traps tied to rheumatoid arthritis: points to ponder. Front Immunol. 2020;11: 578129.","journal-title":"Front Immunol"},{"key":"650_CR17","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1111\/1756-185X.13226","volume":"21","author":"W Wang","year":"2018","unstructured":"Wang W, Peng W, Ning X. Increased levels of neutrophil extracellular trap remnants in the serum of patients with rheumatoid arthritis. Int J Rheum Dis. 2018;21:415\u201321.","journal-title":"Int J Rheum Dis"},{"key":"650_CR18","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1189\/jlb.5BT0615-234R","volume":"99","author":"A Barnado","year":"2016","unstructured":"Barnado A, Crofford LJ, Oates JC. At the Bedside: Neutrophil extracellular traps (NETs) as targets for biomarkers and therapies in autoimmune diseases. J Leukoc Biol. 2016;99:265\u201378.","journal-title":"J Leukoc Biol"},{"issue":"3","key":"650_CR19","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.jbspin.2016.05.013","volume":"84","author":"JM Berthelot","year":"2017","unstructured":"Berthelot JM, Le Goff B, Neel A, Maugars Y, Hamidou M. NETosis: at the crossroads of rheumatoid arthritis, lupus, and vasculitis. Joint Bone Spine. 2017;84(3):255\u201362.","journal-title":"Joint Bone Spine"},{"key":"650_CR20","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.809806","volume":"12","author":"J Zhao","year":"2021","unstructured":"Zhao J, Jiang P, Guo S, Schrodi SJ, He D. Apoptosis, autophagy, NETosis, necroptosis, and pyroptosis mediated programmed cell death as targets for innovative therapy in rheumatoid arthritis. Front Immunol. 2021;12: 809806.","journal-title":"Front Immunol"},{"key":"650_CR21","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.jaut.2017.04.007","volume":"82","author":"C P\u00e9rez-S\u00e1nchez","year":"2017","unstructured":"P\u00e9rez-S\u00e1nchez C, Ruiz-Lim\u00f3n P, Aguirre MA, Jim\u00e9nez-G\u00f3mez Y, Arias-de la Rosa I, \u00c1balos-Aguilera MC, et al. Diagnostic potential of NETosis-derived products for disease activity, atherosclerosis and therapeutic effectiveness in rheumatoid arthritis patients. J Autoimmun. 2017;82:31\u201340.","journal-title":"J Autoimmun"},{"issue":"178","key":"650_CR22","doi-asserted-by":"publisher","first-page":"178ra40","DOI":"10.1126\/scitranslmed.3005580","volume":"5","author":"R Khandpur","year":"2013","unstructured":"Khandpur R, Carmona-Rivera C, Vivekanandan-Giri A, Gizinski A, Yalavarthi S, Knight JS, et al. NETs are a source of citrullinated autoantigens and stimulate inflammatory responses in rheumatoid arthritis. Sci Transl Med. 2013;5(178):178ra40.","journal-title":"Sci Transl Med"},{"issue":"5","key":"650_CR23","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1136\/ard-2022-223568","volume":"82","author":"LJ O\u2019Neil","year":"2023","unstructured":"O\u2019Neil LJ, Oliveira CB, Wang X, Navarrete M, Barrera-Vargas A, Merayo-Chalico J, et al. Neutrophil extracellular trap-associated carbamylation and histones trigger osteoclast formation in rheumatoid arthritis. Ann Rheum Dis. 2023;82(5):630\u20138.","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"650_CR24","doi-asserted-by":"publisher","DOI":"10.1002\/jcla.23662","volume":"35","author":"S Wu","year":"2021","unstructured":"Wu S, Peng W, Liang X, Wang W. Anti-citrullinated protein antibodies are associated with neutrophil extracellular trap formation in rheumatoid arthritis. J Clin Lab Anal. 2021;35(3): e23662.","journal-title":"J Clin Lab Anal"},{"key":"650_CR25","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1093\/rheumatology\/keab289","volume":"61","author":"S Rezende Oliveira","year":"2021","unstructured":"Rezende Oliveira S, Almeida A, de Arruda J, Henriques Schneider A, Florindo Carvalho V, Cavalcante Machado C, Ice Dias Corr\u00ea J, et al. Are neutrophil extracellular traps the link for the cross-talk between periodontitis and rheumatoid arthritis physiopathology? Rheumatology (Oxford). 2021;61:174\u201384.","journal-title":"Rheumatology (Oxford)"},{"issue":"2","key":"650_CR26","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0192365","volume":"13","author":"C Kaneko","year":"2018","unstructured":"Kaneko C, Kobayashi T, Ito S, Sugita N, Murasawa A, Nakazono K, et al. Circulating levels of carbamylated protein and neutrophil extracellular traps are associated with periodontitis severity in patients with rheumatoid arthritis: a pilot case-control study. PLoS ONE. 2018;13(2): e0192365.","journal-title":"PLoS ONE"},{"issue":"3","key":"650_CR27","doi-asserted-by":"publisher","first-page":"R122","DOI":"10.1186\/ar4579","volume":"16","author":"C Sur Chowdhury","year":"2014","unstructured":"Sur Chowdhury C, Giaglis S, Walker UA, Buser A, Hahn S, Hasler P. Enhanced neutrophil extracellular trap generation in rheumatoid arthritis: analysis of underlying signal transduction pathways and potential diagnostic utility. Arthritis Res Ther. 2014;16(3):R122.","journal-title":"Arthritis Res Ther"},{"key":"650_CR28","doi-asserted-by":"publisher","first-page":"631662","DOI":"10.3389\/fimmu.2021.631662","volume":"12","author":"M Luque-T\u00e9var","year":"2021","unstructured":"Luque-T\u00e9var M, Perez-Sanchez C, Pati\u00f1o-Trives AM, Barbarroja N, Arias de la Rosa I, Abalos-Aguilera MC, et al. Integrative clinical, molecular, and computational analysis identify novel biomarkers and differential profiles of anti-TNF response in rheumatoid arthritis. Front Immunol. 2021;12:631662.","journal-title":"Front Immunol"},{"issue":"9","key":"650_CR29","doi-asserted-by":"publisher","first-page":"2569","DOI":"10.1002\/art.27584","volume":"62","author":"D Aletaha","year":"2010","unstructured":"Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT, Bingham CO, et al. 2010 Rheumatoid arthritis classification criteria: An American College of Rheumatology\/European League Against Rheumatism collaborative initiative. Arthritis Rheum. 2010;62(9):2569\u201381.","journal-title":"Arthritis Rheum"},{"key":"650_CR30","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aav5908","author":"AS Byrd","year":"2019","unstructured":"Byrd AS, Carmona-Rivera C, O\u2019Neil LJ, Carlucci PM, Cisar C, Rosenberg AZ, et al. Neutrophil extracellular traps, B cells, and type I interferons contribute to immune dysregulation in hidradenitis suppurativa. Sci Transl Med. 2019. https:\/\/doi.org\/10.1126\/scitranslmed.aav5908.","journal-title":"Sci Transl Med"},{"key":"650_CR31","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.134189","author":"N Seto","year":"2020","unstructured":"Seto N, Torres-Ruiz JJ, Carmona-Rivera C, Pinal-Fernandez I, Pak K, Purmalek MM, et al. Neutrophil dysregulation is pathogenic in idiopathic inflammatory myopathies. JCI Insight. 2020. https:\/\/doi.org\/10.1172\/jci.insight.134189.","journal-title":"JCI Insight"},{"key":"650_CR32","doi-asserted-by":"publisher","first-page":"3573","DOI":"10.1021\/jm0701932","volume":"50","author":"ML P\u00e9rez","year":"2007","unstructured":"P\u00e9rez ML, G\u00f3mara MJ, Ercilla G, Sanmart\u00ed R, Haro I. Antibodies to citrullinated human fibrinogen synthetic peptides in diagnosing rheumatoid arthritis. J Med Chem. 2007;50:3573\u201384.","journal-title":"J Med Chem"},{"key":"650_CR33","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1136\/annrheumdis-2019-216709","volume":"79","author":"R Castellanos-Moreira","year":"2020","unstructured":"Castellanos-Moreira R, Rodr\u00edguez-Garc\u00eda SC, Gomara MJ, Ruiz-Esquide V, Cuervo A, Casafont-Sol\u00e9 I, et al. Anti-carbamylated proteins antibody repertoire in rheumatoid arthritis: evidence of a new autoantibody linked to interstitial lung disease. Ann Rheum Dis. 2020;79:587\u201394.","journal-title":"Ann Rheum Dis"},{"issue":"7","key":"650_CR34","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1136\/ard.60.7.641","volume":"60","author":"M Backhaus","year":"2001","unstructured":"Backhaus M, Burmester GR, Gerber T, Grassi W, Machold KP, Swen WA, et al. Guidelines for musculoskeletal ultrasound in rheumatology [Internet]. Ann Rheum Dis Ann Rheum Dis. 2001;60(7):641\u20139.","journal-title":"Ann Rheum Dis Ann Rheum Dis"},{"key":"650_CR35","first-page":"440","volume":"33","author":"RJ Wakefield","year":"2006","unstructured":"Wakefield RJ, Balint PV, Szkudlarek M, Filippucci E, Backhaus M, D\u2019Agostino MA, Sanchez EN, Iagnocco A, Schmidt WA, Bruyn GA, Kane D, O\u2019Connor PJ, Manger B, Joshua F, Koski J, Grassi W, Lassere MN, Swen N, Kainberger F, Klauser A, Ostergaard M, Brown AK, CPO 7 SIGroup. Musculoskeletal ultrasound including definitions for ultrasonographic pathology. J Rheumatol. 2006;33:440.","journal-title":"J Rheumatol"},{"key":"650_CR36","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1002\/art.10877","volume":"48","author":"M Szkudlarek","year":"2003","unstructured":"Szkudlarek M, Court-Payen M, Jacobsen S, Klarlund M, Thomsen HS, \u00d8stergaard M. Interobserver agreement in ultrasonography of the finger and toe joints in rheumatoid arthritis. Arthritis Rheum. 2003;48:955\u201362.","journal-title":"Arthritis Rheum"},{"issue":"1","key":"650_CR37","doi-asserted-by":"publisher","first-page":"R5","DOI":"10.1186\/ar4431","volume":"16","author":"J Ram\u00edrez","year":"2014","unstructured":"Ram\u00edrez J, Ru\u00edz-Esquide V, Pom\u00e9s I, Celis R, Cuervo A, Hern\u00e1ndez MVMV, et al. Patients with rheumatoid arthritis in clinical remission and ultrasound-defined active synovitis exhibit higher disease activity and increased serum levels of angiogenic biomarkers. Arthritis Res Ther. 2014;16(1):R5.","journal-title":"Arthritis Res Ther"},{"key":"650_CR38","doi-asserted-by":"publisher","first-page":"837","DOI":"10.2307\/2531595","volume":"44","author":"E DeLong","year":"1988","unstructured":"DeLong E, DeLong D, Clarke-Pearson D. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics. 1988;44:837\u201345.","journal-title":"Biometrics"},{"key":"650_CR39","first-page":"5059","volume":"13","author":"X Wang","year":"2020","unstructured":"Wang X, Wang H, Lv X, Wang X. Original article DMARDs combined with acupuncture therapy to treat RA: study of effects on dsDNA\/NETs level and mechanism analysis. Int J Clin Exp Med. 2020;13:5059\u201367.","journal-title":"Int J Clin Exp Med"},{"key":"650_CR40","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1002\/art.41062","volume":"72","author":"M Bach","year":"2020","unstructured":"Bach M, Moon J, Moore R, Pan T, Nelson JL, Lood C. A neutrophil activation biomarker panel in prognosis and monitoring of patients with rheumatoid arthritis. Arthritis Rheumatol. 2020;72:47\u201356.","journal-title":"Arthritis Rheumatol"},{"key":"650_CR41","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.trsl.2016.12.003","volume":"183","author":"P Ruiz-Lim\u00f3n","year":"2017","unstructured":"Ruiz-Lim\u00f3n P, Ortega R, Arias I, de la Rosa M, Abalos-Aguilera DC, Sanchez CP, Gomez YJ, et al. Tocilizumab improves the proatherothrombotic profile of rheumatoid arthritis patients modulating endothelial dysfunction, NETosis, and inflammation. Transl Res. 2017;183:87\u2013103.","journal-title":"Transl Res"},{"issue":"5","key":"650_CR42","doi-asserted-by":"publisher","DOI":"10.1111\/sji.12870","volume":"91","author":"MK Fagerhol","year":"2020","unstructured":"Fagerhol MK, Johnson E, Tangen J, Hollan I, Mirlashari MR, Nissen-Meyer LSH, et al. NETs analysed by novel calprotectin-based assays in blood donors and patients with multiple myeloma or rheumatoid arthritis: a pilot study. Scand J Immunol. 2020;91(5): e12870.","journal-title":"Scand J Immunol"},{"key":"650_CR43","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1080\/14397595.2019.1583819","volume":"30","author":"S Nakabo","year":"2020","unstructured":"Nakabo S, Ohmura K, Akizuki S, Murakami K, Nakashima R, Hashimoto M, et al. Activated neutrophil carbamylates albumin via the release of myeloperoxidase and reactive oxygen species regardless of NETosis. Mod Rheumatol. 2020;30:345\u20139.","journal-title":"Mod Rheumatol"},{"key":"650_CR44","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abd2688","author":"LJ O\u2019Neil","year":"2020","unstructured":"O\u2019Neil LJ, Barrera-Vargas A, Sandoval-Heglund D, Merayo-Chalico J, Aguirre-Aguilar E, Aponte AM, et al. Neutrophil-mediated carbamylation promotes articular damage in rheumatoid arthritis. Sci Adv. 2020. https:\/\/doi.org\/10.1126\/sciadv.abd2688.","journal-title":"Sci Adv"},{"key":"650_CR45","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1038\/nrrheum.2017.15","volume":"13","author":"LA Trouw","year":"2017","unstructured":"Trouw LA, Rispens T, Toes REM. Beyond citrullination: other post-translational protein modifications in rheumatoid arthritis. Nat Rev Rheumatol. 2017;13:331\u20139.","journal-title":"Nat Rev Rheumatol"},{"key":"650_CR46","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1002\/art.27740","volume":"63","author":"JS Smolen","year":"2011","unstructured":"Smolen JS, Aletaha D. Interleukin-6 receptor inhibition with tocilizumab and attainment of disease remission in rheumatoid arthritis: the role of acute-phase reactants. Arthritis Rheum. 2011;63:43\u201352.","journal-title":"Arthritis Rheum"},{"issue":"1","key":"650_CR47","doi-asserted-by":"publisher","first-page":"182","DOI":"10.3390\/diagnostics12010182","volume":"12","author":"B Frade-Sosa","year":"2022","unstructured":"Frade-Sosa B, Ponce A, Ruiz-Esquide V, Garc\u00eda-Y\u00e9benes MJ, Morl\u00e1 R, Sapena N, et al. High sensitivity C reactive protein in patients with rheumatoid arthritis treated with antibodies against IL-6 or Jak inhibitors: a clinical and ultrasonographic study. Diagnostics (Basel). 2022;12(1):182.","journal-title":"Diagnostics (Basel)"},{"key":"650_CR48","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1136\/annrheumdis-2014-205506","volume":"73","author":"MC Turina","year":"2014","unstructured":"Turina MC, Sieper J, Yeremenko N, Conrad K, Haibel H, Rudwaleit M, et al. Calprotectin serum level is an independent marker for radiographic spinal progression in axial spondyloarthritis. Ann Rheum Dis. 2014;73:1\u20133.","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"650_CR49","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1186\/s13075-018-1764-z","volume":"20","author":"J Inciarte-Mundo","year":"2018","unstructured":"Inciarte-Mundo J, Ramirez J, Hern\u00e1ndez MV, Ruiz-Esquide V, Cuervo A, Cabrera-Villalba SR, et al. Calprotectin strongly and independently predicts relapse in rheumatoid arthritis and polyarticular psoriatic arthritis patients treated with tumor necrosis factor inhibitors: a 1-year prospective cohort study. Arthritis Res Ther. 2018;20(1):275.","journal-title":"Arthritis Res Ther"},{"key":"650_CR50","doi-asserted-by":"publisher","first-page":"kead641","DOI":"10.1093\/rheumatology\/kead641","volume":"4","author":"K Sejersen","year":"2023","unstructured":"Sejersen K, Weitoft T, Knight A, Lysholm J, Larsson A, R\u00f6nnelid J. Serum calprotectin correlates stronger with inflammation and disease activity in ACPA positive than ACPA negative rheumatoid arthritis. Rheumatology (Oxford). 2023;4:kead641.","journal-title":"Rheumatology (Oxford)"}],"container-title":["Rheumatology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40744-024-00650-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40744-024-00650-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40744-024-00650-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,22]],"date-time":"2024-05-22T12:17:57Z","timestamp":1716380277000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40744-024-00650-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,2]]},"references-count":50,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["650"],"URL":"https:\/\/doi.org\/10.1007\/s40744-024-00650-9","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-3359000\/v1","asserted-by":"object"}]},"ISSN":["2198-6576","2198-6584"],"issn-type":[{"value":"2198-6576","type":"print"},{"value":"2198-6584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,2]]},"assertion":[{"value":"15 November 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 February 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 March 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Beatriz Frade-Sosa received support for attending meetings and\/or speaker honoraria from Pfizer, AbbVie, Lilly, BMS, Gal\u00e1pagos, Sandoz and GSK. Laura Mac\u00edas received support for attending meetings and\/or travel from Diasorin in 19 October (LabClin Congress). Juan Camilo Sarmiento-Monroy received support for attending meetings and\/or speaker honoraria from Pfizer, AbbVie, Lilly, BMS, Gal\u00e1pagos, Astrazeneca and GSK. Jose A. G\u00f3mez-Puerta received speaker honoraria from AbbVie, BMS, Gal\u00e1pagos, GSK, Lilly, Pfizer, Sanofi and Roche. Raimon Sanmart\u00ed received speaker honoraria and\/or investigation grants from AbbVie, BMS, Gebro-Pharma, Lilly, MSD, Pfizer, Sandoz. Sanofi and Roche. Andr\u00e9s Ponce, Est\u00edbaliz Ruiz, Noemi de Moner, Mar\u00eda J G\u00f3mara, Ana Bel\u00e9n Azuaga, Rosa Morl\u00e0, Virginia Ruiz-Esquide, Nuria Sapena, Lola Tobalina, Julio Ramirez, Juan D Ca\u00f1ete, Jordi Yague, Josep M. Aug\u00e9, Odette Vi\u00f1as and Isabel Haro declare they have no conflicts of interest. No pharmaceutical companies have participated or influenced the development of this manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This study was conducted in accordance with the Declaration of Helsinki and was approved by the Clinical Research Ethics Committee of the Hospital Clinic of Barcelona (Reg. HCB20210783). Informed consent was obtained from all patients before enrolment in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}